PCN173 - COST-EFFECTIVENESS OF NEW TRIPLET COMBINATIONS WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.256
https://www.valueinhealthjournal.com/article/S1098-3015(18)33556-3/fulltext
Title :
PCN173 - COST-EFFECTIVENESS OF NEW TRIPLET COMBINATIONS WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33556-3&doi=10.1016/j.jval.2018.09.256
First page :
Section Title :
Open access? :
No
Section Order :
1895